| Monocarboxylate transporter MCT1 promotes tumor metastasis independently of its activity as a lactate transporter VL Payen, MY Hsu, KS Rädecke, E Wyart, T Vazeille, C Bouzin, ... Cancer research 77 (20), 5591-5601, 2017 | 122 | 2017 |
| Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia E Wyart, MY Hsu, R Sartori, E Mina, V Rausch, ES Pierobon, ... EMBO reports 23 (4), e53746, 2022 | 35 | 2022 |
| Cachexia, a systemic disease beyond muscle atrophy E Wyart, LB Bindels, E Mina, A Menga, S Stanga, PE Porporato International journal of molecular sciences 21 (22), 8592, 2020 | 35 | 2020 |
| Metabolic alterations in a slow‐paced model of pancreatic cancer‐induced wasting E Wyart, S Reano, MY Hsu, DL Longo, M Li, E Hirsch, N Filigheddu, ... Oxidative Medicine and Cellular Longevity 2018 (1), 6419805, 2018 | 22 | 2018 |
| Assessing metabolic dysregulation in muscle during cachexia MY Hsu, PE Porporato, E Wyart Cancer Metabolism: Methods and Protocols, 337-352, 2019 | 2 | 2019 |
| FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy E Mina, E Wyart, R Sartori, E Angelino, I Zaggia, V Rausch, M Maldotti, ... Cell Reports Medicine 4 (12), 2023 | 1 | 2023 |
| Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia A Dolly, SA Pötgens, MM Thibaut, AM Neyrinck, GS de Castro, C Galbert, ... Journal of cachexia, sarcopenia and muscle 14 (3), 1569-1582, 2023 | 1 | 2023 |
| Monocarboxylate transporter 1 (MCT1) promotes tumor metastasis independently of its activity as a transporter of lactate V Payen, MY Hsu, KS Radecke, E Wyart, T Vazeille, C Bouzin, ... ISCaM2018, 2018 | | 2018 |
